We are live on ! Find out more
EAM

EULAV Asset Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 23.04%
This Fund
S&P 500
This Quarter Est. Return
+2.05%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$1.86B
AUM Growth
-$31M
Cap. Flow
-$42.7M
Cap. Flow %
-2.3%
Top 10 Hldgs %
14.75%
Holding
298
New
30
Increased
59
Reduced
86
Closed
12

Top Buys

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$8.98M
2
CRM icon
Salesforce
CRM
+$7.84M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$7.02M
4
DXCM icon
DexCom
DXCM
+$6.73M
5
ADBE icon
Adobe
ADBE
+$6.46M

Top Sells

Rank Stock Value
1
SBAC icon
SBA Communications
SBAC
+$11.6M
2
NXPI icon
NXP Semiconductors
NXPI
+$10.8M
3
CVS icon
CVS Health
CVS
+$8.54M
4
BFH icon
Bread Financial
BFH
+$7.48M
5
SLGN icon
Silgan Holdings
SLGN
+$6.92M

Sector Composition

Rank Sector Weight
1 Industrials 20.94%
2 Technology 16.75%
3 Healthcare 16.72%
4 Consumer Discretionary 14.9%
5 Financials 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CB icon
76
Chubb
CB
$140B
$8.03M 0.43%
60,800
+8,000
+15% +$1.02M
GIS icon
77
General Mills
GIS
$20.2B
$8.03M 0.43%
130,000
-782
-0.6% -$48.4K
HCSG icon
78
Healthcare Services Group
HCSG
$1.61B
$7.74M 0.42%
197,500
ESRX
79
DELISTED
Express Scripts Holding Company
ESRX
$7.71M 0.42%
112,140
NKE icon
80
Nike
NKE
$64.1B
$7.57M 0.41%
149,000
-46,000
-24% -$2.36M
FMC icon
81
FMC
FMC
$1.25B
$7.56M 0.41%
154,041
BMRN icon
82
BioMarin Pharmaceuticals
BMRN
$11.9B
$7.54M 0.41%
91,000
-1,000
-1% -$86K
IEX icon
83
IDEX
IEX
$17B
$7.38M 0.4%
81,950
JPM icon
84
JPMorgan Chase
JPM
$916B
$7.33M 0.39%
85,000
+7,000
+9% +$534K
STZ icon
85
Constellation Brands
STZ
$22.5B
$7.21M 0.39%
47,000
+15,000
+47% +$2.38M
MBLY
86
DELISTED
Mobileye N.V.
MBLY
$7.21M 0.39%
189,000
AGN
87
DELISTED
Allergan plc
AGN
$7.14M 0.38%
33,980
-18,000
-35% -$3.73M
WWD icon
88
Woodward
WWD
$23B
$7.04M 0.38%
102,000
MNST icon
89
Monster Beverage
MNST
$95.1B
$7.01M 0.38%
316,000
+4,000
+1% +$91.6K
SNX icon
90
TD Synnex
SNX
$19.9B
$6.87M 0.37%
113,600
JAZZ icon
91
Jazz Pharmaceuticals
JAZZ
$16.1B
$6.87M 0.37%
+63,000
New +$7.02M
NEU icon
92
NewMarket
NEU
$7.24B
$6.82M 0.37%
16,100
AKAM icon
93
Akamai
AKAM
$15.6B
$6.8M 0.37%
102,000
-45,000
-31% -$2.87M
INFO
94
DELISTED
IHS Markit Ltd. Common Shares
INFO
$6.8M 0.37%
192,054
SJI
95
DELISTED
South Jersey Industries, Inc.
SJI
$6.75M 0.36%
200,400
OTEX icon
96
Open Text
OTEX
$6.28B
$6.74M 0.36%
218,000
+1,000
+0.5% +$31.2K
DIS icon
97
Walt Disney
DIS
$171B
$6.67M 0.36%
64,000
-53,000
-45% -$5.17M
PEP icon
98
PepsiCo
PEP
$196B
$6.59M 0.35%
63,000
-459
-0.7% -$48.1K
BAC icon
99
Bank of America
BAC
$429B
$6.52M 0.35%
295,000
+75,000
+34% +$1.44M
BKNG icon
100
Booking.com
BKNG
$156B
$6.45M 0.35%
110,000
-5,000
-4% -$299K

Similar funds

EULAV Asset Management's Q4 2016 Portfolio in Review

As of Q4 2016, EULAV Asset Management held 298 positions worth $1.86B, down 1.6% from $1.89B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

EULAV Asset Management's Q4 2016 filing shows 30 new, 59 increased, 86 reduced and 12 closed positions. Its largest new stake was Pioneer Natural Resource Co.: 49,000 shares worth $8.82M. The largest sale was SBA Communications, an estimated $11.6M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

  • EULAV Asset Management's largest Q4 2016 buy was Pioneer Natural Resource Co.: 49,000 shares worth $8.82M.
  • EULAV Asset Management added most to Salesforce in Q4 2016, an estimated $7.84M increase.
  • EULAV Asset Management's biggest Q4 2016 reduction was CVS Health, cutting an estimated $8.54M.
  • EULAV Asset Management fully exited SBA Communications in Q4 2016, selling an estimated $11.6M.
  • EULAV Asset Management's ten largest holdings make up 15% of its $1.86B portfolio in Q4 2016.
  • EULAV Asset Management opened 30 new positions and closed 12 in Q4 2016.
  • EULAV Asset Management's portfolio value fell 1.6% quarter-over-quarter to $1.86B.

Based on EULAV Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.